FDA approves Zelboraf (vemurafenib)
First and only personalized medicine shown to help people with…
17 August 2011 | By Roche
First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma...
List view / Grid view
First and only personalized medicine shown to help people with…
17 August 2011 | By Roche
First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma...
Roche announced that a Phase III study (BRIM3) showed vemurafenib…
5 June 2011 | By Roche
Roche announced that a Phase III study (BRIM3) showed vemurafenib (RG7204, PLX4032) significantly improved overall survival in people with previously untreated BRAF V600 mutation...